WDM(SH:600055) Cai Jing Wang·2026-02-02 07:44Core Viewpoint - WanDong Medical (600055) expects a net profit loss of approximately 199 million to 257 million yuan for the fiscal year 2025, with a net profit loss excluding non-recurring gains and losses estimated at 213 million to 271 million yuan [1] Group 1: Financial Performance - The company has adjusted its marketing strategy to adapt to market changes, successfully winning imaging equipment projects with more competitive pricing, which has impacted gross margins and compressed net profit margins [1] - The anticipated losses for 2025 reflect the challenges faced in maintaining profitability amid strategic shifts and market conditions [1] Group 2: Strategic Initiatives - The company is increasing its R&D investment and actively expanding into overseas markets while strengthening marketing efforts in high-grade domestic hospitals, contributing to its strategic transformation towards high-end and international markets [1] - To address structural challenges in the industry, the company is hiring specialized R&D personnel and enhancing its comprehensive layout in high-end medical imaging equipment, particularly in CT, MR, and DSA categories [1] Group 3: Technological Development - The company focuses on the R&D of core components and high-performance equipment, establishing a technology reserve framework of "research generation, reserve generation, and development generation" [1] - Efforts to deepen overseas market penetration include improving the overseas marketing organizational structure and functions, implementing overseas station expansions, and building regional service centers to enhance medical accessibility [1]